Prader-Willi syndrome


Also found in: Dictionary, Medical, Acronyms, Wikipedia.

Prader-Willi syndrome

[¦präd·ər ¦wil·ē ′sin‚drōm]
(medicine)
A genetic disorder that is caused by defects on the paternally derived chromosome 15, causing mild mental retardation, neonatal hypotonia, hypogonadism, compulsive overeating, childhood onset obesity, and mild facial dysmorphism.
Mentioned in ?
References in periodicals archive ?
We present the anesthetic management of a 31-yearold patient diagnosed with Prader-Willi syndrome who was scheduled to undergo bariatric surgery.
In the past the Prader-Willi syndrome was diagnosed based on the clinical presentation, but genetic testing can now more accurately diagnose the condition.
The report provides a snapshot of the global therapeutic landscape of Prader-Willi Syndrome (PWS)
Sadly, there is no cure for the condition, but if a child with Prader-Willi syndrome is able to follow a restricted diet and control their weight, there's no reason why they can't enjoy a good quality of life.
Prader-Willi syndrome is a condition that leads to poor muscle tone, motor skills, difficulties in learning, behavioural problems, short physique, decreased production of sex hormones, hunger, and obesity.
Now Isabella's parents Stuart and Helen Bailey, from Northumberland Park, North Tyneside, have completed a walk to raise money for the Prader-Willi Syndrome Association UK.
Activity there kicked on in most of the participants, except for those with Prader-Willi syndrome.
It is also administered to children who fail to grow because of chronic renal insufficiency or significant genetic abnormalities, including Turner syndrome, Noonan syndrome, and Prader-Willi syndrome.
Three-year-old Rhun Edwards, of Porthmadog, suffers from Prader-Willi Syndrome, which affects muscle growth, and leaves many sufferers confined to a wheelchair.
Prader-Willi syndrome (PWS), a neurodevelopmental disorder identified as a frequent cause of genetic obesity, is a common condition encountered in genetic clinics worldwide.
Omnitrope had recently been approved for the treatment of children with growth failure due to Prader-Willi syndrome and treatment of children small for gestational age.